Profile
Sector:
Consumer DefensiveIndustry:
Packaged FoodsCountry:
United StatesIPO:
15 May 2015Website:
http://www.arcadiabio.comNext earnings report:
28 February 2025Last dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 20 Nov 2024 21:00:00 GMTDividend
Analysts recommendations
Institutional Ownership
RKDA Latest News
RKDA witnesses a solid 55% improvement in Zola sales in Q3. The company continues to invest to grow the Zola brand.
Arcadia Biosciences (RKDA) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $1.83 per share a year ago.
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President & Chief Executive Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Operator Good afternoon, and welcome to Arcadia Biosciences Third Quarter 2024 Financial Results and Business Highlights Conference Call.
Arcadia Biosciences (RKDA) witnesses a solid 42% improvement in Zola sales in Q2. The company continues to invest to grow the Zola brand through mass market retailers and grocery store chains.
Arcadia Biosciences (RKDA) came out with quarterly earnings of $0.78 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to loss of $2.64 per share a year ago.
LOS ANGELES--(BUSINESS WIRE)--Prime Therapeutics Fails to Silence AHF in PBM Price-Fixing Arbitration.
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2024 after market close on August 13, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can joi.
Arcadia Biosciences (RKDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Arcadia Biosciences (RKDA) is using the sale of its GoodWheat brand to expand its wheat intellectual property.
Arcadia Biosciences, Inc.® (Nasdaq: RKDA) will be hosting a call for analysts and investors on May 22, 2024, after the market closes. The conference call, scheduled for 4:30 p.m. Eastern time (1:30 p.m. Pacific time), will focus on recent strategic transactions. Interested participants can join the call through an audio-only webcast.
- 1(current)
What type of business is Arcadia Biosciences?
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
What sector is Arcadia Biosciences in?
Arcadia Biosciences is in the Consumer Defensive sector
What industry is Arcadia Biosciences in?
Arcadia Biosciences is in the Packaged Foods industry
What country is Arcadia Biosciences from?
Arcadia Biosciences is headquartered in United States
When did Arcadia Biosciences go public?
Arcadia Biosciences initial public offering (IPO) was on 15 May 2015
What is Arcadia Biosciences website?
https://www.arcadiabio.com
Is Arcadia Biosciences in the S&P 500?
No, Arcadia Biosciences is not included in the S&P 500 index
Is Arcadia Biosciences in the NASDAQ 100?
No, Arcadia Biosciences is not included in the NASDAQ 100 index
Is Arcadia Biosciences in the Dow Jones?
No, Arcadia Biosciences is not included in the Dow Jones index
When was Arcadia Biosciences the previous earnings report?
No data
When does Arcadia Biosciences earnings report?
The next expected earnings date for Arcadia Biosciences is 28 February 2025